Tag: big pharma

FDA Warns of Deaths Linked to Drug It Wants Removed From Market

The Food and Drug Administration said in a March 31 alert that it has learned of eight deaths linked to a drug called avacopan that is used to treat blood vessel inflammation.

A review of studies, documents from avacopan manufacturer Amgen, and reports to the FDA’s adverse event reporting system resulted in the identification of 76 cases of drug-induced liver injury “with reasonable evidence of a causal association with avacopan use,” the FDA said in a drug safety alert.

Fifty-four of the cases led to hospitalization, and eight ended in death.

Some of the cases involved a syndrome that features the destruction of bile ducts in the liver, which can lead to permanent liver damage.

“Patients should contact their health care professional immediately if they develop any signs or symptoms that may indicate liver injury, such as: feeling more tired than usual; nausea; vomiting; unusual itching; light-colored stools; yellowing of skin or eyes; dark urine; swelling in the stomach or abdomen; or pain in the right upper abdomen,” the FDA stated. “Patients should talk to their health care professional about the safety risks associated with Tavneos and whether to continue therapy or switch to alternative treatments.”

Avacopan, also known as Tavneos, was approved by the FDA in 2021 for the treatment of severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis, or blood vessel inflammation.

Keep reading

The American Mind Has Collapsed: How Vaccine Damage and Tribal Stupidity Created a Nation of Gullible Fools

How Mainstream America Became Dumb… and then Dumber

I’ve spent years observing, documenting, and sounding the alarm about the erosion of American intelligence and discernment. Today, I believe we are witnessing not just a cultural or political decline, but a mass cognitive collapse — a deliberate, engineered stupidity that has rendered a once-critical populace into a nation of gullible fools.

This is not an accident. It is the culmination of a multi-front war on human cognition, waged through toxic vaccines, processed food poisons, electromagnetic pollution, and a relentless propaganda machine that celebrates mediocrity and punishes truth. The evidence is everywhere, from the halls of government to the checkout line at the grocery store. We have crossed a cognitive event horizon, and the path back to reason seems all but lost [1]. Here’s how we got here, and why it matters for the survival of freedom itself.

The Unprecedented Decline of American Intelligence

The data is in, and it’s grim. Across all ages and demographics, test results show Americans are getting dumber [2]. This isn’t a minor dip in scores; it’s a systemic plunge. I believe this mass cognitive decline is largely driven by physical and chemical assaults on the brain, with vaccine damage playing a central role. The adjuvants in vaccines, particularly aluminum, are a silent, pervasive threat [3]. Studies have found high aluminum levels in patients with Alzheimer’s, autism, and epilepsy, and this neurotoxic substance is directly injected into the population, especially infants [3].

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction [4]. This is not speculation; it is documented science that the corrupt medical establishment desperately wants you to ignore. When you combine this with the brain-damaging effects of other environmental toxins like lead [5], glyphosate in food, and electromagnetic fields from 5G, you have a perfect storm for neurological decay. The once-critical American mind, capable of innovation and self-governance, has been replaced with a gullible, tribalistic stupidity that I find unprecedented in our history. We are becoming a population of psychological zombies, primed to believe anything our tribal leaders tell us [6].

The Artemis Moon Farce: A Case Study in Celebrating Nothing

Nothing exemplifies this collapse of basic reasoning more than the public’s reaction to NASA’s Artemis program. Celebrating a flight that’s merely planned to go around the moon as “going back” to the moon reveals a total failure of logic and an embrace of empty symbolism. This manufactured triumph is a perfect symbol of an empire that can no longer distinguish reality from propaganda, nor achievement from theatrics.

This isn’t about space exploration; it’s about the degradation of meaning. A society that celebrates a symbolic loop as a monumental return has lost its ability to assess value and substance. It eagerly consumes the spectacle while ignoring the substance — or lack thereof. This willingness to applaud a non-event is a symptom of a deeper sickness: a population so cognitively damaged that it cannot perform the most basic reality checks. It is ready to be sold any story, no matter how hollow, as long as it’s wrapped in the flag and accompanied by a press release. The provided sources on this specific NASA mission are limited, but the pattern of celebrating engineered narratives over tangible reality is a hallmark of our cognitive decline.

Keep reading

FDA Launches New AI-Powered System to Track Drug and Vaccine Side Effects

For decades, the system designed to catch dangerous side effects from drugs, vaccines, and consumer products has been failing. Not because the problems weren’t happening — but because the infrastructure meant to track them was too fragmented, too slow, and too burdensome to keep up.

The result was a growing gap between what patients experienced and what showed up in federal safety records. Patterns of harm went undetected or took far too long to surface, and the public was left making health decisions based on an incomplete picture.

Now the U.S. Food and Drug Administration (FDA) is attempting to close that gap with a sweeping technology overhaul — one that could fundamentally change how quickly you see safety signals and how much control you have over your own health choices. Here’s what the new system does, what it replaces, and why it matters.

Keep reading

Biden officials pushed COVID booster harder after surveillance found stroke increase: Sen. Johnson

The Biden administration pushed COVID-19 boosters for elderly people even harder after its vaccine safety surveillance systems discovered, as early as November 2022, “statistically significant safety signals for ischemic stroke” in that age group following uptake of the Pfizer bivalent, Sen. Ron Johnson, R-Wis., told Secretary of Health and Human Services Robert F. Kennedy in a letter Monday, disclosed Wednesday.

The Permanent Subcommittee on Investigations chair released nearly 2,000 pages of “relevant HHS records” in conjunction with the letter, in 10 batches, documenting the stroke signal and internal communications between officials “acknowledging significant statistical limitations in their ability to detect safety signals through their data analyses.”

The Biden White House next made edits to a draft Centers for Disease Control and Prevention and Food and Drug Administration “communications plan” to increase booster uptake, in January 2023, that “downplayed the significance of the safety signal, changing a sentence that stated that the ‘signal is moderately elevated’ to the ‘signal is slightly elevated,'” Johnson told Kennedy.

“Biden health officials posted on FDA’s website that ‘no change is recommended in COVID-19 vaccination practice,'” the same month, even as they “initiated multiple studies and statistical analyses — including a so-called ‘Stroke Project” — to investigate the validity of their assertion” through at least September 2025, Johnson’s office said.

He asked Kennedy for more information about detection of ischemic stroke following the booster because “the full extent of HHS’s awareness of the ischemic stroke safety signal remains incomplete and key records are still missing.”

Biden officials downplayed the risk of ischemic stroke they found in coadministered COVID and flu vaccines in fall 2023.

Several months earlier they approved “additional investigation” of the booster stroke signal even while emphasizing they weren’t changing vaccine recommendations, but quickly dismissed the signal after using a “different methodology.“

Keep reading

Bayer’s Monsanto sues mRNA COVID-19 vaccine makers

Bayer’s agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, claiming that they used its patent-protected technology in their products.

One lawsuit – filed in a federal court in Delaware – asserts that Pfizer/BioNTech’s Comirnaty and Moderna’s Spikevax vaccines, which generated tens of billions of dollars in revenues during the pandemic, used technology developed by Monsanto in the 1980s designed to eliminate ‘problem’ coding sequences in the building blocks of cells “to improve mRNA stability and the amount or quality of protein produced” in crops.

The technology was awarded a US patent in 2010 (No. 7,741,118) and is not due to expire until June 2027. According to the suit, Pfizer/BioNTech and Moderna used it to stabilise their mRNA vaccines.

“To develop effective mRNA medicines, defendants needed to stabilise the mRNA molecule and optimise its protein expression,” it claims, adding that they “optimised and manufactured their infringing mRNA vaccine products starting with a DNA template” and using Monsanto’s patented process.

Meanwhile, Reuters has also reported that Bayer independently filed a similar lawsuit against Johnson & Johnson in a New Jersey federal court, contending that a DNA-based process the company used in manufacturing its adenovirus vector-based COVID-19 vaccine also infringes the patent.

The shot – known as the Janssen vaccine – won emergency authorisations in the US and other markets and made blockbuster sales in the pandemic before its use diminished due to concerns about rare clotting side effects. It was withdrawn from sale in the US in 2023.

While sales are well down on their peak, Comirnaty brought in worldwide revenues of more than $3.3 billion for Pfizer and BioNTech last year, with Moderna earning $3.2 billion from Spikevax.

Bayer has said it does not intend to do anything that would restrict the commercial use of the COVID-19 vaccines – although, that is already being achieved due to changing immunisation policies in the US under the Trump administration – but is seeking damages “in an amount adequate to compensate” for the infringement of its intellectual property and royalties on sales.

Keep reading

Pfizer Says Lyme Vaccine Missed Trial Target, Will Still Seek Approval

Pfizer and its partner Valneva said on March 23 that their experimental Lyme disease vaccine did not meet the target in a clinical trial, but that the results were strong enough that the firms will seek regulatory approval for the shot.

The vaccine, known as LB6V, was about 75 percent efficacious in reducing confirmed Lyme in recipients compared with placebo recipients, the companies said. The efficacy was measured one day after the fourth vaccine dose, and was similar to the 73 percent efficacy observed 28 days after the fourth shot.

The drugmakers said that because there were fewer Lyme cases than expected during the trial, dubbed VALOR, the predetermined statistical target was not met. However, because the efficacy was “clinically meaningful,” the companies expressed confidence in the shot and said they would be filing for approval.

“The efficacy shown in the VALOR study of more than 70 percent is highly encouraging and creates confidence in the vaccine’s potential to protect against this disease that can be debilitating,” Annaliesa Anderson, Pfizer’s chief vaccines officer, said in a statement.

Valneva CEO Thomas Lingelbach said: “[The results] bring us a step closer to our goal of delivering a much-needed vaccine.

“We are grateful to our partner Pfizer for their strong commitment which we both share in developing this vaccine as quickly as possible.”

Keep reading

Owners and CEO of Wholesale Pharmaceutical Company Sentenced for Distributing More Than $92M of Black-Market HIV Drugs

Two owners of a pharmaceutical wholesale company were sentenced Friday to a total of 38 years in prison for orchestrating a complex, nationwide drug diversion scheme that harmed vulnerable HIV-positive patients, placed countless others at risk, and corrupted the supply chain for prescription drugs in the United States.

“Patrick and Charles Boyd did not just commit fraud and cost taxpayers millions of dollars, they preyed upon some of the most vulnerable members of our society: HIV patients who depend on life-saving treatments to manage their disease,” said Assistant Attorney General A. Tysen Duva of the Justice Department’s Criminal Division. “Fraud schemes like this one undermine the integrity of our supply chain for necessary prescription drugs. These defendants will rightly spend years in prison for their reprehensible conduct, which took advantage of people for illicit profit. This case is another example of how the Criminal Division, our United States Attorney partner in the Southern District of Florida, and law enforcement will pursue and seek convictions of those who defraud our systems, endanger our citizens, and seek to line their pockets with fraud proceeds.”

“These defendants treated life-saving HIV medication like street contraband,” said U.S. Attorney Jason A. Reding Quiñones for the Southern District of Florida. “They bought drugs off the street from black-market suppliers, shipped them in dirty boxes and discarded packaging, falsified paperwork, and pushed those medications back into the legitimate pharmaceutical supply chain. The consequences were real. HIV patients received bottles containing the wrong drugs, and at least one patient lost consciousness after ingesting medication that should never have been in that bottle. As a former military prosecutor, federal prosecutor, and trial judge, I have seen how greed can drive dangerous schemes. When criminals gamble with patient safety for profit, federal prison is the result.”

“Friday’s sentence underscores the extreme danger these defendants created,” said Acting Deputy Inspector General for Investigations Scott J. Lampert of the U.S. Department of Health and Human Services, Office of Inspector General (HHS‑OIG). “They took life‑threatening actions that showed an alarming disregard for human life in service of nothing more than a payday. Their criminal scheme endangered vulnerable patients, put entire communities at risk, and undermined the integrity of Medicare and Medicaid. HHS‑OIG will continue working with our law enforcement partners — and using every tool in our arsenal — to pursue and dismantle illegal black‑market rings that seek to corrupt the nation’s drug supply and exploit taxpayer‑funded health care programs.”

Keep reading

AP Shills For Big Pharma Antidepressants With ‘Bewildering’ Hit Piece

Cruising through X last week a weird story caught my eye: it reported that The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, was trying to hire a “friend” who wants the FDA to add warnings to antidepressants about “unproven pregnancy risks.” The story makes several claims that are bewildering and appear to be fabricated. I sent several questions to AP’s global health editor Jonathan Fahey, but he did not respond to repeated requests to explain the article’s puzzling errors.

AP reporter Matthew Perrone later blocked me on X. I’ve pasted my email to Fahey at the bottom of this article.

The person AP’s Matthew Perrone identifies as a “friend” of FDA’s Hoeg is Dr. Adam Urato, chief of maternal-fetal medicine at Metro West Medical Center in Massachusetts.

One passage in the AP story stood out to me:

Within the agency, Hoeg’s close relationship with Urato is viewed as a clear conflict of interest that, under normal FDA standards, would result in her recusing herself from any work on the petition. But Hoeg is actively working to speed up the agency’s review of her friend’s proposal, according to the people familiar with the situation.

I have never seen the term “friend” defined as a “conflict of interest” by any federal agency. Nor have I run across “friend” defined as a “conflict of interest” in the peer-reviewed scientific literature. It’s a conflict of interest that doesn’t seem to exist.

And I happen to know quite a bit about conflicts of interest in science, because I’m an expert on the matter.

While I was a Senate staffer, I wrote a law on conflicts of interest called the Physicians Payments Sunshine Act. The bill I wrote was later passed into law and you can now go look up doctors on the government’s Open Payments website to see who is giving them money. I’m sure AP reporters use this website all the time. During my time in the Senate, I also helped to reform conflicts of interest at the National Institutes of Health. This took thousands of hours, untold numbers of meetings, and years of work to complete.

When I left the Senate and joined the Safra Ethics Center at Harvard, I was celebrated as the “Father of Sunshine” for this work to reform conflicts of interest in medicine.

Confused by the AP’s confusing reporting, I contacted Health and Human Services (HHS) and FDA, sending them almost the exact same questions that I sent to AP’s Jonathan Fahey.

“Being a friend is not a violation of ethics or conflicts of interests’ laws,” wrote HHS spokesman Andrew Nixon, in an email. Several senior FDA officials told me that HHS doesn’t even have a legal definition for what a “friend” is and no government conflict of interest form asks people to identify who their friends are.

“It’s a hit piece from industry against Dr. Hoeg, who is doing an amazing job at the FDA,” said one FDA official.

Hoeg did not respond to requests for comment, but during a phone call, Urato told me the AP story was filled with fake facts. The FDA has not offered him a full-time job as AP reported, and if they did, he couldn’t take it as he has a full-time clinical practice with hundreds of patients. FDA has expressed interest in offering him a limited, part-time position as an “advisor,” but nothing has been formalized.

He’s known Hoeg for only a couple years, and met her once when he went to DC to testify in favor of a labelling change for antidepressants that warns pregnant women about the documented risks for fetuses.

“This whole thing is being made up, and it’s an absurdity,” Urato said. “I’m not close friends with her as we’ve only discussed work. But If I say I’m not friends with her, then it’s like saying I’m her enemy.”

Keep reading

Unlike other industries, vaccine manufacturers are shielded from safety design defects

The entire vaccine programme is one giant depopulation and profit extraction scam, with the childhood schedule being especially devastating in terms of both its fraud and potential lifelong harms.

The National Childhood Vaccine Injury Act (“NCVIA”) of 1986 allowed for Big Pharma and its intelligence-industrial complex handlers to ramp up their injectable democide offerings without any consequences or even a need to bother pretending that they were not openly maiming and murdering innocents by producing a single randomised controlled trial (“RCT”) with placebo control; to wit:

It is painfully obvious by now that all vaccines are all risk and no reward whatsoever.  Read more: If All Vaccines Are Unsafe And Ineffective, Then Why Are They Being Foisted on Humanity?, 2nd Smartest Guy in the World, 2 February 2025

Keep reading

Declassified CIA files reveal chilling blueprint to manipulate Americans’ minds through covert drugging with vaccines

A newly released CIA document reveals a chilling blueprint to manipulate minds through covert drugging experiments.

The report, added to the CIA’s reading room in 2025, details the government’s once top-secret Project Artichoke that ran from 1951 to 1956, focusing on behavior control, interrogation techniques and psychological manipulation.

The seven-page document, titled ‘Special Research for Artichoke,’ with an attachment labeled ‘Suggested Fields for Special Research Relative Artichoke,’ outlines proposals to develop chemicals capable of altering human behavior.

It discusses drugs designed for both immediate effects, like truth serums and long-term influence, potentially administered through food, water, alcohol or cigarettes.

Researchers also suggested that such substances could be disguised in medical treatments such as vaccinations or injections.

The CIA was also looking into methods beyond chemicals, listing hypnosis, sensory deprivation, gases and other psychological methods for interrogation and behavioral control.

Artichoke served as a precursor to the CIA’s MKUltra program, which later broadened mind-altering experiments on a larger scale.

Many files were destroyed in the 1970s, leaving the full extent of the research and how far it progressed unknown.

The document was declassified in 1983, but has resurfaced on social media, where users are shocked to see the CIA discussing methods for ‘drugging entire populations.’

Project Artichoke emerged during the early Cold War, a period marked by intense anxiety over communist powers and reports of brainwashing techniques used on American prisoners of war in Korea. 

Internal CIA memos suggested that US intelligence feared enemy nations had developed ways to control human thought and behavior, prompting the agency to explore its own capabilities.

The declassified document reveals the depth of this research, noting the need for a study ‘to determine what drugs are best suited for direct use on subjects along the lines of amytal and pentothal and which drugs are best for an indirect or long-range approach to subjects.’ 

The researchers involved in the secret program emphasized that long-term compounds should be capable of producing ‘an agitating effect (producing anxiety, nervousness, tension, etc.) or a depressing effect (creating a feeling of despondency, hopelessness, lethargy, etc.).’ 

They also outlined practical considerations for concealment, such as substances that could be introduced surreptitiously in ‘food, water, Coca-Cola, beer, liquor, cigarettes, etc.,’ highlighting the CIA’s focus on undetectable methods of influence. 

Moreover, the report recommended consulting with the Army Chemical Warfare Service, noting they have conducted ‘exhaustive studies along these lines’ that could provide specific guidance for the program.

Beyond drugs, Artichoke explored a wide range of psychological tools. 

Keep reading